Stryker [SYK] vs Dexcom [DXCM] Detailed Stock Comparison

Stryker Corporation

NYSE
Loading...

Dexcom Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Stryker Corporation wins in 11 metrics, Dexcom Inc. wins in 9 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Stryker Corporation Dexcom Inc. Better
P/E Ratio (TTM) 39.21 30.03 Dexcom Inc.
Price-to-Book Ratio 5.62 8.63 Stryker Corporation
Debt-to-Equity Ratio 72.97 50.85 Dexcom Inc.
PEG Ratio 0.72 0.39 Dexcom Inc.
EV/EBITDA 19.90 19.85 Dexcom Inc.
Profit Margin (TTM) 12.92% 17.94% Dexcom Inc.
Operating Margin (TTM) 27.24% 25.64% Stryker Corporation
EBITDA Margin (TTM) 27.24% 25.64% Stryker Corporation
Return on Equity 15.08% 34.50% Dexcom Inc.
Return on Assets (TTM) 7.92% 8.89% Dexcom Inc.
Free Cash Flow (TTM) $4.28B $1.08B Stryker Corporation
Dividend Yield 0.97% N/A N/A
1-Year Return -17.25% -8.07% Dexcom Inc.
Price-to-Sales Ratio (TTM) 5.02 5.10 Stryker Corporation
Enterprise Value $138.30B $23.09B Stryker Corporation
EV/Revenue Ratio 5.51 4.95 Dexcom Inc.
Gross Profit Margin (TTM) 64.54% 62.93% Stryker Corporation
Revenue per Share (TTM) $66 $12 Stryker Corporation
Earnings per Share (Diluted) $8.40 $2.05 Stryker Corporation
Beta (Stock Volatility) 0.93 1.56 Stryker Corporation
Short % of Float 1.20% 4.93% Stryker Corporation

Stryker Corporation vs Dexcom Inc. Stock Performance Analysis

Loading Price Chart...

SYK
DXCM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%
Dexcom Inc.-1.53%-3.13%20.43%11.88%12.92%11.54%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%
Dexcom Inc.-8.07%-42.07%-27.92%315.26%2,149.85%2,129.88%

Performance & Financial Health Analysis: Stryker Corporation vs Dexcom Inc.

MetricSYKDXCM
Market Information
Market Cap i$126.25B$23.76B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,881,4064,652,604
90 Day Avg. Volume i2,161,1394,100,848
Last Close$307.94$74.22
52 Week Range$281.00 - $404.87$54.11 - $89.98
% from 52W High-23.94%-17.52%
All-Time High$406.19 (Jan 27, 2025)$164.86 (Nov 15, 2021)
% from All-Time High-24.19%-54.98%
Growth Metrics
Quarterly Revenue Growth0.11%0.13%
Quarterly Earnings Growth0.56%0.76%
Financial Health
Profit Margin (TTM) i0.13%0.18%
Operating Margin (TTM) i0.27%0.26%
Return on Equity (TTM) i0.15%0.35%
Debt to Equity (MRQ) i72.9750.85
Cash & Liquidity
Book Value per Share (MRQ)$58.61$7.14
Cash per Share (MRQ)$10.71$5.19
Operating Cash Flow (TTM) i$5.04B$1.44B
Levered Free Cash Flow (TTM) i$4.17B$719.54M
Dividends
Last 12-Month Dividend Yield i0.97%N/A
Last 12-Month Dividend i$3.40N/A

Valuation & Enterprise Metrics Analysis: Stryker Corporation vs Dexcom Inc.

MetricSYK (Apr 24, 2026)DXCM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i39.2130.03
Forward P/E i19.6720.59
PEG Ratio i0.720.39
Price to Sales (TTM) i5.025.10
Price to Book (MRQ) i5.628.63
Market Capitalization
Market Capitalization i$126.25B$23.76B
Enterprise Value i$138.30B$23.09B
Enterprise Value Metrics
Enterprise to Revenue i5.514.95
Enterprise to EBITDA i19.9019.85
Risk & Other Metrics
Beta i0.931.56
Book Value per Share (MRQ) i$58.61$7.14

Financial Statements Comparison: Stryker Corporation vs Dexcom Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSYK (2025)DXCM (2025)
Revenue/Sales i25.12B4.66B
Cost of Goods Sold i9.05B1.86B
COGS % of Revenue i36.0%39.9%
Gross Profit i16.07B2.80B
Gross Margin i64.0%60.1%
Research & Development i1.62B599.10M
Operating Income (EBIT) i5.06B911.80M
Operating Margin i20.1%19.6%
EBITDA i6.48B1.36B
EBITDA Margin i25.8%29.1%
Pre-Tax Income i4.51B1.09B
Pre-Tax Income % of Revenue i18.0%23.3%
Income Tax i1.27B252.10M
Income Tax % of Revenue i5.0%5.4%
Net Income (Profit) i3.25B836.30M
Profit Margin i12.9%17.9%

Balance Sheet & Liquidity Metrics

MetricSYK (2025)DXCM (2025)
Cash & Equivalents i4.01B917.70M
Total Current Assets i14.76B4.03B
Total Current Assets % of Revenue i58.7%86.5%
Total Current Liabilities i7.79B2.14B
Total Current Liabilities % of Revenue i31.0%46.0%
Long-Term Debt i14.86B1.37B
Long-Term Debt % of Revenue i59.2%29.3%
Total Shareholders Equity i22.42B2.75B
Retained Earnings i20.47B2.43B
Retained Earnings % of Revenue i81.5%52.2%
Property, Plant & Equipment i1.79B77.40M

Cash Flow Statement Comparison

MetricSYK (2025)DXCM (2025)
Operating Cash Flow i4.70B1.48B
Operating Cash Flow % of Revenue i18.7%31.7%
Capital Expenditures i-761.00M-363.50M
Free Cash Flow i4.28B1.08B
FCF Margin i17.1%23.1%
Debt Repayment i-1.40B-1.21B
Common Stock Repurchase iN/A-500.00M

Short Interest & Institutional Ownership Analysis

MetricSYKDXCM
Shares Short i4.42M14.72M
Short Ratio i1.953.77
Short % of Float i1.20%4.93%
Shares Outstanding i382.50M384.80M
Float Shares i346.55M382.94M
% Held by Insiders i5.37%0.28%
% Held by Institutions i82.09%101.50%
% Held by Public i12.54%-1.78%

Dividend Analysis & Yield Comparison: Stryker Corporation vs Dexcom Inc.

MetricSYKDXCM
Last 12-Month Dividend i$3.40N/A
Last 12-Month Dividend Yield i0.97%N/A
3-Year Avg Annual Dividend i$3.23N/A
3-Year Avg Dividend Yield i0.24%N/A
3-Year Total Dividends i$9.69N/A
Ex-Dividend DateDec 31, 2025N/A